Rench Wealth Management, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 918 filers reported holding NOVARTIS A G in Q3 2015. The put-call ratio across all filers is 1.29 and the average weighting 0.6%.

Quarter-by-quarter ownership
Rench Wealth Management, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2019$3,135,000
+12.2%
33,106
+3.0%
1.81%
+0.1%
Q3 2019$2,793,000
-0.6%
32,140
+4.5%
1.80%
+0.3%
Q2 2019$2,809,000
-5.2%
30,764
-0.2%
1.80%
-7.2%
Q1 2019$2,964,000
+13.2%
30,827
+1.0%
1.94%
+1.1%
Q4 2018$2,619,000
+0.6%
30,522
+1.0%
1.92%
+10.5%
Q3 2018$2,603,000
+14.6%
30,208
+0.5%
1.74%
+5.8%
Q2 2018$2,271,000
-8.4%
30,059
-2.0%
1.64%
-3.2%
Q1 2018$2,479,000
-6.5%
30,658
-2.9%
1.70%
-1.7%
Q4 2017$2,650,000
+4.4%
31,563
+6.8%
1.72%
-1.4%
Q3 2017$2,538,000
+11.0%
29,560
+7.9%
1.75%
+3.4%
Q2 2017$2,287,000
+11.8%
27,399
-0.5%
1.69%
+11.4%
Q1 2017$2,045,000
+3.4%
27,541
+1.5%
1.52%
-3.1%
Q4 2016$1,977,000
-2.7%
27,142
+5.5%
1.57%
-4.6%
Q3 2016$2,032,000
-40.8%
25,736
-38.1%
1.64%
-40.8%
Q2 2016$3,430,000
+22.1%
41,567
+7.2%
2.77%
+20.0%
Q1 2016$2,809,000
-12.7%
38,782
+3.8%
2.31%
-16.8%
Q4 2015$3,216,000
-6.0%
37,378
+0.4%
2.78%
-11.7%
Q3 2015$3,421,000
-6.7%
37,217
-0.1%
3.14%
-1.7%
Q2 2015$3,665,000
-4.2%
37,268
-4.0%
3.20%
-2.5%
Q1 2015$3,827,000
-48.3%
38,807
-51.4%
3.28%
+5.1%
Q4 2014$7,402,000
+92.0%
79,884
+95.0%
3.12%
-5.3%
Q3 2014$3,856,000
+5.7%
40,960
+1.7%
3.29%
+3.5%
Q2 2014$3,647,000
+11.6%
40,285
+4.8%
3.18%
+2.7%
Q1 2014$3,269,000
+140.2%
38,455
+127.2%
3.10%
+135.1%
Q4 2013$1,361,00016,9291.32%
Other shareholders
NOVARTIS A G shareholders Q3 2015
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders